Sort
48,018 grants matching “immunotherapy”
Regulatory T Cells in Autoimmune Disease
$903,038David A. Hafler · Brigham And Women'S Hospital · U19 · FY2007 · AI
Cancer Immunotherapy Clinical Trials
$902,872Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Personalized cancer models to discover and develop new therapeutic targets.
$902,672Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2017 · CA
SPORE in Pancreatic Cancer
$902,341University Of Alabama At Birmingham · P20 · FY2004 · CA
Nonhuman Primate Antibody Resource for Immune Cell Depletion
$902,336Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · P40 · FY2025 · OD
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
$902,223David G Kirsch · Roswell Park Cancer Institute Corp · R35 · FY2023 · CA
WASHINGTON D.C. CONSORTIUM PEDIATRIC AIDS CLINICAL TRIAL
$901,958Children'S National Medical Center · U01 · FY2000 · AI
Immunotherapeutics Against Other Filovirus Threats
$901,735Jonathan R. Lai · Scripps Research Institute, The · U19 · FY2014 · AI
Pacific Ovarian Cancer Research Consortium
$901,655Charles Drescher · Fred Hutchinson Cancer Research Center · P50 · FY2015 · CA
Effect of tumor editing on antitumor immunity
$901,205Judy Lieberman · Boston Children'S Hospital · R35 · FY2025 · CA
Development of PSMA -based recombinant protein vaccines
$900,492Progenics Pharmaceuticals, Inc. · R44 · FY2005 · CA
NANO2 ENHANCES IMMUNOTHERAPY IN TRIPLE NEGATIVE BREAST CANCERS.
$900,418Nuvox Pharma, L.L.C. · · FY2022 · Defense Health Agency
CCR, LGI, Flow Cytometry Core Facility
$900,397Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Xenogeneic Stem Cell and Thymic Replacement in AIDS
$900,000Massachusetts General Hospital · P01 · FY2001 · AI
The Johns Hopkins Translational Science Team for the ET-CTN
$900,000Michael A. Carducci · Johns Hopkins University · UM1 · FY2015 · CA
Tumor Plasticity
$900,000Dario C. Altieri · Wistar Institute · R35 · FY2017 · CA
SPORE in Pancreatic Cancer
$900,000University Of Alabama At Birmingham · P20 · FY2003 · CA
The Johns Hopkins Translational Science Team for the ET-CTN
$899,999Michael A. Carducci · Johns Hopkins University · UM1 · FY2014 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$899,988David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
Allergen Loaded Nanoparticles for Food Allergy Tolerance
$899,903Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
$899,727Laurence J.n. Cooper · University Of Tx Md Anderson Can Ctr · R33 · FY2010 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$899,708William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
ANTI-RAN TARGETING IMMUNOTHERAPY FOR C9ORF72 ALS AND GENETICALLY UNKNOWN RAN-POSITIVE SPORADIC ALS
$899,603University Of Florida · · FY2025 · Defense Health Agency
Project 1: Transgenic TCR-mediated tumor therapy
$899,284Philip D Greenberg · University Of Washington · P01 · FY2022 · CA
Immuno-Targeted Therapy for Melanoma
$899,241Antoni Ribas · University Of California Los Angeles · R35 · FY2020 · CA